MaxCyte Inc. | Income Statement
Fiscal year is January-December. All values GBP Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
4,353.50
4,351.10
6,080.80
9,093.20
10,859.40
12,499.60
Cost of Goods Sold (COGS) incl. D&A
517.30
581.50
675.30
969.10
1,128.30
1,379.90
Gross Income
3,836.20
3,769.60
5,405.50
8,124.10
9,731.10
11,119.70
SG&A Expense
4,334.20
4,531.20
5,870.80
10,088.60
16,985.00
17,432
EBIT
497.90
761.60
465.40
1,964.50
7,254.00
6,312.30
Non Operating Income/Expense
16.90
13.20
19.70
42.20
38.90
121.70
Interest Expense
98.20
340.90
461.10
472.70
485.50
460.90
Pretax Income
613.00
1,115.70
946.10
2,479.40
7,700.60
6,651.50
Consolidated Net Income
613.00
1,115.70
946.10
2,479.40
7,700.60
6,651.50
Net Income
613.00
1,115.70
946.10
2,479.40
7,700.60
6,651.50
Net Income After Extraordinaries
613.00
1,115.70
946.10
2,479.40
7,700.60
6,651.50
Net Income Available to Common
1,828.30
3,828.20
2,302.70
2,854.00
7,700.60
6,651.50
EPS (Basic)
26.77
15.80
1.22
0.08
0.16
0.13
Basic Shares Outstanding
68.30
242.30
1,887.80
33,515.70
48,642.90
51,182.40
EPS (Diluted)
26.78
15.80
1.22
0.09
0.16
0.13
Diluted Shares Outstanding
68.30
242.30
1,887.80
33,515.70
48,642.90
51,182.40
EBITDA
423.50
705.70
404.30
1,886.20
7,143.00
6,054.40
Preferred Dividends
1,215.30
2,712.50
1,356.60
374.60
-
-
About MaxCyte
View Profile
